Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

AREV Life Sciences Global Corp. (AREVF)

Compare
0.0100
+0.0100
(0.00%)
As of April 11 at 4:00:00 PM EDT. Market Open.
Loading Chart for AREVF
  • Previous Close 0.0100
  • Open 0.0100
  • Bid 0.0050 x --
  • Ask 0.0150 x --
  • Day's Range 0.0100 - 0.0100
  • 52 Week Range 0.0050 - 0.1050
  • Volume 10,000
  • Avg. Volume 546
  • Market Cap (intraday) 317,624
  • Beta (5Y Monthly) 6.85
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.

www.arevlifesciences.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AREVF

View More

Performance Overview: AREVF

Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

AREVF
0.00%
S&P/TSX Composite index (^GSPTSE)
3.37%

1-Year Return

AREVF
100.00%
S&P/TSX Composite index (^GSPTSE)
8.64%

3-Year Return

AREVF
94.35%
S&P/TSX Composite index (^GSPTSE)
8.86%

5-Year Return

AREVF
82.64%
S&P/TSX Composite index (^GSPTSE)
66.86%

Compare To: AREVF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AREVF

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    317.62k

  • Enterprise Value

    419.46k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    62.01

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    82.07

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -42.42%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    7.21k

  • Net Income Avi to Common (ttm)

    -239.54k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.82k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -83.09k

Research Analysis: AREVF

View More

Company Insights: AREVF

Research Reports: AREVF

View More

People Also Watch